Category Archives: Clinical Cardiology

In a room of 20 people, its likely that about 10 of them, or half, will presently have some form of cardiovascular disease (CVD). CVD is among the most prevalent diseases in the U.S., and strokes and other CVDs are on the rise globally Continue reading →

The Heartland Partnership Represents USHVs First in Kansas. Continue reading →

To gain approval by the FDA, drugs typically need to be proven safe and effective in rigorous, randomized clinical trials. Often, these trials are blinded: The patients and researchers do not know which patients received the standard treatment or the experimental treatment Continue reading →

April 21, 2023 2 min read ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Back to Healio Women hospitalized with acute coronary syndrome who have metabolic syndrome are 1.7 times more likely to experience a major adverse CV or cerebrovascular event if they also have comorbid obstructive sleep apnea, researchers reported. Continue reading →

When Dr. Rajesh Rajan chose cardiology as his field of study, he wanted to explore the numerous possibilities for heart patients around the world for better healthcare Continue reading →

Photo courtesy of SLV HealthDr Carla Christ, MD, General Surgery, poses with a Savi Scout. By: By John Waters, Courier News Editor Updated: 3 hours ago / Posted Apr 27, 2023 ALAMOSA Hospitals in rural areas are cornerstone institutions that offer a bevy of benefits to the communities they serve Continue reading →

April 27, 2023 2 min read Disclosures: Greene reports receiving research support from Amgen, AstraZeneca, Bristol Myers Squibb, Cytokinetics, Merck, Novartis, Pfizer and Sanofi; serving on advisory boards for Amgen, AstraZeneca, Bristol Myers Squibb, Boehringer Ingelheim/Eli Lilly, Cytokinetics, Roche Diagnostics, scPharmaceuticals and Sanofi; receiving speaker fees from Boehringer Ingelheim, Cytokinetics and Roche Diagnostics; and serving as a consultant for Amgen, Bayer, Bristol Myers Squibb, Corteria Pharmaceuticals, CSL Vifor, Merck, PharmaIN, Roche Diagnostics, Sanofi, Tricog Health and Urovant Pharmaceuticals. Continue reading →

April 27, 2023 Ultromics, a leader in the field of artificial intelligence-powered diagnostics for heart failure, has been granted FDA Breakthrough Device Status for its AI-enhanced platform for detecting cardiac amyloidosis. The platform, EchoGo Amyloidosis, uses artificial intelligence to analyze echocardiograms and detect the presence of cardiac amyloidosis, a condition caused by deposits of abnormal proteins in the heart tissue, using only a single commonly acquired ultrasound view of the heart. The novel technology is designed to address the unmet need for earlier diagnosis of amyloidosis patients, which otherwise may go unnoticed until the disease has advanced, delaying treatment, and adversely impacting patient outcomes. Continue reading →

PORTLAND, OR, UNITED STATE, April 27, 2023 /EINPresswire.com/ -- Nanomedicine Market- Global Outlook and Forecast 2023-2030 is latest research study released by Allied Market Research evaluating the market risk side analysis, highlighting opportunities and leveraged with strategic and tactical decision-making support (2023-2030). Continue reading →

Newswise Arlington Heights, Ill., April 27, 2023 -- The Society for Clinical Trials (SCT) is pleased to announce that the prestigious David Sackett Trial of the Year Award will be presented to The Chronic Hypertension and Pregnancy (CHAP) Trial. The award will be presented on May 24, 2023, as part of SCTs 44th Annual Meeting, Championing High-quality Evidence to Optimize Human Health, May 21 - 24 at the Baltimore Marriott Waterfront Hotel. Continue reading →